Vaxcyte
PCVX
55.39
-2.97
-5.09%
Vaxcyte
US · PCVX
#1630 by market cap
Listed 2020
55.39
-2.97
-5.09%
Periodic snapshot; not a real-time feed.
· 2026-11-20 19:30
Quant vs Street three independent views, side by side
StockVane factor grade
B-
Momentum strategy signal
Sell
Analyst consensus
Buy
Mostly aligned, one view stands apart.
Not investment advice. The factor grade ranks this stock on fundamentals against StockVane's covered universe; the momentum strategy signal is a rules-based backtest, not a recommendation; analyst consensus reflects sell-side coverage. The three use different methods and can reasonably disagree.
Analyst consensus 9 analysts
Buy
Avg price target 115.63 +108.8%
Price target rangecurrent 55.39
Low75.00
Avg115.63
High163.00
Buy 89%
Hold 11%
Sell 0%
Recent ratings (25)
| Date | Firm | Analyst | Rating | Target |
|---|---|---|---|---|
| 2026-11-05 | TD Cowen | -- | Buy | 75.00 |
| 2026-11-05 | BofA Securities | -- | Buy | -- |
| 2026-11-04 | BTIG | -- | Buy | 89.00 |
| 2026-10-18 | Guggenheim | -- | Buy | 125.00 |
| 2026-10-12 | Cantor Fitzgerald | -- | Buy | 120.00 |
| 2026-10-06 | Goldman Sachs | -- | Hold | 85.00 |
| 2026-10-05 | Mizuho Securities | -- | Buy | 163.00 |
| 2026-10-05 | BofA Securities | -- | Buy | 146.00 |
| 2026-10-05 | Jefferies | -- | Buy | 146.00 |
| 2026-10-05 | Needham | -- | Buy | 122.00 |
| 2026-10-05 | Guggenheim | -- | Buy | 125.00 |
| 2026-09-28 | BofA Securities | -- | Buy | -- |
| 2026-09-25 | Needham | -- | Buy | 110.00 |
| 2026-08-06 | Needham | -- | Buy | 110.00 |
| 2026-08-05 | TD Cowen | -- | Buy | 75.00 |
| 2026-08-05 | BofA Securities | -- | Buy | 133.00 |
| 2026-08-05 | Guggenheim | -- | Buy | 116.00 |
| 2026-07-29 | BTIG | -- | Buy | 89.00 |
| 2026-06-26 | Needham | -- | Buy | 110.00 |
| 2026-06-18 | Mizuho Securities | -- | Buy | 163.00 |
| 2026-06-02 | Mizuho Securities | -- | Buy | 163.00 |
| 2026-05-21 | Evercore | -- | Buy | -- |
| 2026-05-07 | BofA Securities | -- | Buy | -- |
| 2026-05-07 | Needham | -- | Buy | 110.00 |
| 2026-05-06 | TD Cowen | -- | Buy | 75.00 |
Price target trend monthly average, last 3 years
Earnings history price reaction on the day
| Period | Report date | Session | Options expected | Actual move |
|---|---|---|---|---|
| 2025/Q4 | 2026-02-24 | After close | ±9.54% | +2.75% (in line) |
| 2024/Q4 | 2025-02-25 | After close | ±17.57% | -0.88% (in line) |
| 2023/Q4 | 2024-02-27 | After close | ±12.24% | -7.33% (in line) |
| 2022/Q4 | 2023-02-27 | After close | ±15.57% | -3.14% (in line) |
| 2021/Q4 | 2022-02-28 | -- | ±15.02% | +2.52% (in line) |
| 2020/Q4 | 2021-03-29 | -- | -- | -4.34% |
"Options expected" is the pre-earnings options market's implied move (a straddle-style estimate), shown next to what actually happened.
Quote time 2026-11-20 19:30:05 · For reference only, not investment advice and not tailored to your situation.
Vaxcyte discussion 0 comments